Screener
Cytokinetics CYTK PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 17,989 | 16,990 |
| Total current assets | 1,208,487 | 916,975 |
| Long-term investments | 538,317 | 335,048 |
| Property and equipment, net | 78,916 | 79,194 |
| Operating lease right-of-use assets | 72,896 | 75,979 |
| Inventories, long-term | 6,529 | — |
| Other assets | 19,406 | 17,341 |
| Total assets | $1,924,551 | $1,424,537 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Cytokinetics's PP&E (net)?
- Cytokinetics (CYTK) reported PP&E (net) of $78.92M in Q2 2026.
- How has Cytokinetics's PP&E (net) changed year-over-year?
- Cytokinetics's PP&E (net) increased by 12.4% year-over-year, from $70.22M to $78.92M.
- What is the long-term trend for Cytokinetics's PP&E (net)?
- Over 5 years (2020 to 2025), Cytokinetics's PP&E (net) has grown at a 42.8% compound annual growth rate (CAGR), from $13.35M to $79.19M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Cytokinetics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude